Hospital Acquired Pneumonia Drugs Market to Touch US$3.8 Bn by 2020
According to the report, six major phase III drugs will collectively generate revenue to the tune of US$3.8 bn by 2020.These findings are detailed in the report, titled 'Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.'
View full press release